<DOC>
	<DOCNO>NCT00521521</DOCNO>
	<brief_summary>To evaluate efficacy concomitant combination radiotherapy docetaxel without cisplatin term objective response rate ( WHO criteria ) .</brief_summary>
	<brief_title>Study Combination Docetaxel Radiotherapy With Without Cisplatin Treat Local Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients locally advanced head neck cancer ( T3 T4 tumor ) , epidermoid , histologically prove without metastasis ; primitive site oral cavity , oropharynx , hypopharynx larynx . Locally advanced tumor inoperable , operable patient refuse surgery . Age ≥ 18 year ≤ 70 year . PS &lt; 2 . Satisfactory hematological , hepatic renal function : ( PN ≥ 2000/mm3 , platelet count ≥ 100,000/mm3 , hemoglobin ≥ 10g/dl , serum creatinine ≤ 120 µmol/l creatinine clearance ≥ 60 ml/mn , normal total bilirubin , AST ( SGOT ) ALT ( SGPT ) ≤ 2.5 x upper limit normal ( ULN ) center , PAL ≤ 5 x LNS ; patient AST ALT &gt; 1.5 x LNS combine PAL &gt; 2.5 x LNS eligible trial . Any metastasis ( cervical ganglion ) . Cancer cavum facial structure . Any previous chemotherapy radiotherapy , irrespective reason . Any surgery epidermoid carcinoma upper aerodigestive tract . Weight loss ≥10 % total body weight last 3 month . Any previous cancer except situ cutaneous cervical cancer ( spinocellular basocellular ) . Pregnant nursing woman ; woman childbearing potential must use appropriate method contraception . Poorly control progressive infection . Peripheral neuropathy NCI grade ≥ 2 . Neurological psychiatric disease ( dementia , seizure , etc . ) compatible good understanding sufficient compliance treatment . Any poorly control progressive disease , heart failure , symptomatic cardiac rhythm disorder , progressive angina pectoris , respiratory impairment . Any concomitant investigational treatment . Any concomitant anticancer treatment . Allergy polysorbate 80 . Definitive formal contraindication corticosteroid . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>